Annual Congress Copenhagen 2005


Material from 2005:
  • 4063 Abstracts
  • 739 Slide presentations
  • 213 Webcasts
  • 93 Handouts
Material from 2005:  Show


Biological agents in the therapy of sarcoidosis

Hot topics
Chairs: M. Spiteri (Stoke-on-Trent, United Kingdom), R. P. Baughman (Cincinnati, United States of America)
Based on our current understanding of the immunopathogenesis of sarcoidosis, this symposium will give an update on latest developments in identifying alternative drugs to reduce steroid-related side-effects in sarcoidosis. Promising molecules are biological agents targeted on the selective inhibition of TNF-α, the major cytokine in the induction of granuloma formation. The results of a randomised, double blind trial with a TNF-α antagonist for chronic pulmonary sarcoidosis will be presented.

Download all media Download all media
 No content
  made available
4176 Immunopathogenesis of sarcoidosis: identifying targets for therapy
J. Muller-Quernheim (Freiburg, Germany)
 [+]  Slide presentation Webcast 4177 Standard therapy for sarcoidosis
U. Costabel (Essen, Germany)
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
 [+]  Slide presentation Webcast 4178 Results of a randomized, double blind trial of anti-tumor necrosis antibody for sarcoidosis
R. P. Baughman (Cincinnati, United States of America)
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
 [+]  Slide presentation Webcast 4179 The future of targeted therapies for sarcoidosis
C. Agostini (Padova, Italy)
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
0
Read or add comments and rate material  
    Bookmark this material     Share or cite